According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -HK$79.64. In 2022 the company made an earnings per share (EPS) of -HK$102.98 an increase over its 2021 EPS that were of -HK$110.12.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$80.31 | -22.01% |
2022 | -HK$102.98 | -6.48% |
2021 | -HK$110.12 | 54.35% |
2020 | -HK$71.34 | 6.98% |
2019 | -HK$66.69 | 2.38% |
2018 | -HK$65.14 | -34.38% |
2017 | -HK$99.26 | 48.84% |
2016 | -HK$66.69 | -35.18% |
2015 | -HK$102.88 |